Published Studies Related to Amlodipine and Valsartan (Amlodipine / Valsartan)
Well-designed clinical trials related to Amlodipine and Valsartan (Amlodipine / Valsartan)
Indirect treatment comparison between fixed-dose-combinations of
amlodipine/losartan and amlodipine/valsartan in blood pressure control. [2014]
Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian
hypertensive patients inadequately controlled with amlodipine monotherapy. [2010]
Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension. [2009]
Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination
with amlodipine: a review of factorial-design studies. [2009]
Efficacy and tolerability of amlodipine/valsartan combination therapy in
hypertensive patients not adequately controlled on valsartan monotherapy. [2009]
Outcomes in hypertensive patients at high cardiovascular risk treated with
regimens based on valsartan or amlodipine: the VALUE randomised trial. [2004]
Comparative effects of valsartan versus amlodipine on left ventricular mass and
reactive oxygen species formation by monocytes in hypertensive patients with left
ventricular hypertrophy. [2004]
Valsartan, a new angiotensin II antagonist for the treatment of essential
hypertension: a comparative study of the efficacy and safety against amlodipine. [1996]
Well-designed clinical trials possibly related to Amlodipine and Valsartan (Amlodipine / Valsartan)
Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic
combination therapy in obese, hypertensive African American and white patients. [2013]
Valsartan improves endothelial dysfunction in hypertension: a randomized,
double-blind study. [2009]
Cost-effectiveness analysis: controlled-release nifedipine and valsartan
combination therapy in patients with essential hypertension: the adalat CR and
valsartan cost-effectiveness combination (ADVANCE-Combi) study. [2008]
Application in the STRATHE trial of a score system to compare the efficacy and
the tolerability of different therapeutic strategies in the management of
hypertension. [2008]
Olmesartan medoxomil: current status of its use in monotherapy. [2006]
Controlled release nifedipine and valsartan combination therapy in patients with
essential hypertension: the adalat CR and valsartan cost-effectiveness
combination (ADVANCE-combi) study. [2006]
Managing hypertension in high-risk patients: lessons and promises from the
STRATHE and ADVANCE trials. [2006]
The importance of early antihypertensive efficacy: the role of angiotensin II
receptor blocker therapy. [2006]
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension
and high cardiovascular risk. [2003]
Evaluation of angiotensin II receptor blockers for 24-hour blood pressure
control: meta-analysis of a clinical database. [2003]
Microalbuminuria reduction with valsartan in patients with type 2 diabetes
mellitus: a blood pressure-independent effect. [2002]
Telmisartan: a review of its use in hypertension. [2001]
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE
trial. The Valsartan Antihypertensive Long-term Use Evaluation. [2001]
Other research related to Amlodipine and Valsartan (Amlodipine / Valsartan)
Formulation and bioequivalence of two Valsartan/Amlodipine immediate release
tablets after a single oral administration. [2014]
Comparative effect of canrenone or hydrochlorothiazide addition to
valsartan/amlodipine combination on urinary albumin excretion in well-controlled
type 2 diabetic hypertensive patients with microalbuminuria. [2014]
Effects of valsartan versus amlodipine in diabetic hypertensive patients with or
without previous cardiovascular disease. [2013]
Valsartan/amlodipine compared to nifedipine GITS in patients with hypertension
inadequately controlled by monotherapy. [2013]
Other possibly related research studies
[Effect of Jiangzhi Kangyanghua mixture on high-sensitivity C-reactive protein
and vascular endothelial functions of hypertension patients]. [Article in Chinese] [2013]
Overview of clinical use and side effect profile of valsartan in Chinese
hypertensive patients. [2013]
Genome-wide response to antihypertensive medication using home blood pressure
measurements: a pilot study nested within the HOMED-BP study. [2013]
Pharmacokinetics, tolerability, and safety of the single oral administration of
AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers. [2014]
Heart rate variability on antihypertensive drugs in black patients living in
sub-Saharan Africa. [2014]
Effect of renin-angiotensin system blockade on soluble Klotho in patients with
type 2 diabetes, systolic hypertension, and albuminuria. [2013]
|